Gujarat Themis Biosyn Ltd Financials

Gujarat Themis Biosyn Ltd Financial Statement

Gujarat Themis Biosyn Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	35.04	39.35	43.03
Operating Expense	19.33	20.28	21.08
Net Profit	10.57	13.24	15.89
Net Profit Margin	30.17	33.65	36.93
Earning Per Share	0.97	1.82	2.19
EBIDTA	15.71	19.03	21.85
Effective Tax Rate	23.04	23.96	22.64

Particulars	Sep 2024
Revenue	35.04
Operating Expense	19.33
Net Profit	10.57
Net Profit Margin	30.17
Earning Per Share	0.97
EBIDTA	15.71
Effective Tax Rate	23.04

Gujarat Themis Biosyn Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	169.82	148.39	114.85
Operating Expenses Annual	91.09	74.76	56.81
Operating Profit Annual	83.10	80.22	62.10
Interest Annual	0.23	0.18	0.83
Depreciation	4.06	2.58	2.23
Net Profit Annual	59.16	57.97	43.62
Tax Annual	20.17	19.50	15.41

Particulars	Mar 2024
Total Revenue Annual	169.82
Operating Expenses Annual	91.09
Operating Profit Annual	83.10
Interest Annual	0.23
Depreciation	4.06
Net Profit Annual	59.16
Tax Annual	20.17

Gujarat Themis Biosyn Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	6.06	0.26	3.97
Cash Flow from Operations	64.21	39.48	40.31
Cash Flow from Investing	-55.21	-20.41	-29.83
Cash Flow from Financing	-8.59	-13.27	-14
Cash Flow at the End	6.47	6.06	0.46

Particulars	Mar 2024
Cash Flow at the Beginning	6.06
Cash Flow from Operations	64.21
Cash Flow from Investing	-55.21
Cash Flow from Financing	-8.59
Cash Flow at the End	6.47

Gujarat Themis Biosyn Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	48.93	54.06	54.07
PBIT Margin (%)	46.85	52.32	52.13
PBT Margin (%)	-156.84	-238.39	-10.66
Net PROFIT Margin (%)	34.84	39.07	37.98
Return On Networth / Equity (%)	33.76	45.92	50.35
Return On Networth /Employed (%)	44.82	60.85	66.38
Return On Assets (%)	33.44	45.32	48.23
Total Debt / Equity (X)	0.01	0.01	0.03
Asset Turnover Ratio (%)	0.96	1.16	1.27

Particulars	Mar 2024
PBDIT Margin (%)	48.93
PBIT Margin (%)	46.85
PBT Margin (%)	-156.84
Net PROFIT Margin (%)	34.84
Return On Networth / Equity (%)	33.76
Return On Networth /Employed (%)	44.82
Return On Assets (%)	33.44
Total Debt / Equity (X)	0.01
Asset Turnover Ratio (%)	0.96

Gujarat Themis Biosyn Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	38.02	32.66	19.43
Total Current Assets Annual	47.56	61.73	78.39
Non Current Assets Annual	173.55	104.60	44.11
Total Shareholders Funds Annual	201.38	149.15	103.32
Total Assets Annual	221.11	166.33	122.50

Particulars	Mar 2024
Fixed Assets Annual	38.02
Total Current Assets Annual	47.56
Non Current Assets Annual	173.55
Total Shareholders Funds Annual	201.38
Total Assets Annual	221.11

Gujarat Themis Biosyn Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, Gujarat Themis Biosyn Ltd has a market capitalization of 2,877.41 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Gujarat Themis Biosyn Ltd is debt-free with a debt-to-equity ratio of 0.01.

In FY 2023 , Gujarat Themis Biosyn Ltd recorded a total revenue of approximately 169.82 Cr marking a significant milestone in the company's financial performance.

Gujarat Themis Biosyn Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.8% and 0.2% annually, respectively..

Gujarat Themis Biosyn Ltd's current PE ratio is 48.64.

Gujarat Themis Biosyn Ltd's ROCE averaged 49.4% from the FY ending March 2022 to 2024, with a median of 51.9%. It peaked at 57.3% in March 2022, reflecting strong capital efficiency over the period..

Gujarat Themis Biosyn Ltd's latest EBIT is Rs. 79.56 Cr, surpassing the average EBIT of Rs. 72.35 Cr over the 5 years..